Sabby Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-15,000
| Closed | -$52K | – | 132 |
|
|
2021
Q1 | $52K | Sell |
15,000
-50,000
| -77% | -$173K | 0.01% | 81 |
|
|
2020
Q4 | $218K | Sell |
65,000
-14,470
| -18% | -$48.5K | 0.04% | 41 |
|
|
2020
Q3 | $279K | Buy |
79,470
+2,500
| +3% | +$8.78K | 0.04% | 51 |
|
|
2020
Q2 | $354K | Sell |
76,970
-30,607
| -28% | -$141K | 0.07% | 29 |
|
|
2020
Q1 | $356K | Buy |
107,577
+13,226
| +14% | +$43.8K | 0.15% | 24 |
|
|
2019
Q4 | $576K | Sell |
94,351
-30,437
| -24% | -$186K | 0.16% | 13 |
|
|
2019
Q3 | $520K | Buy |
124,788
+41,857
| +50% | +$174K | 0.28% | 22 |
|
|
2019
Q2 | $1.09M | Buy |
+82,931
| New | +$1.09M | 1.37% | 12 |
|